Who are .02% Chlorohexidine Gluconate's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Lavasept 0.04%, adapalene/benzoyl peroxide, Chlorhexidine 0.2% Mouthrinse, Chlorhexidine rinse, Chlorhexidine oral care, Adapalene/benzoyl peroxide gel, 0.1%/2.5%.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/02-chlorohexidine-gluconate.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

.02% Chlorohexidine Gluconate — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

.02% Chlorohexidine Gluconate (.02% Chlorohexidine Gluconate) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antimicrobial/Antiseptic agent. Area: Oral Health / Infection Prevention.

marketed Antimicrobial/Antiseptic agent Bacterial cell membrane and proteins Oral Health / Infection Prevention Small molecule Live · refreshed every 30 min

Target snapshot

.02% Chlorohexidine Gluconate (.02% Chlorohexidine Gluconate) — Riyadh Colleges of Dentistry and Pharmacy. Chlorhexidine gluconate is a broad-spectrum antimicrobial agent that disrupts bacterial cell membranes and denatures proteins, providing antiseptic and disinfectant effects.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
.02% Chlorohexidine Gluconate TARGET	.02% Chlorohexidine Gluconate	Riyadh Colleges of Dentistry and Pharmacy	marketed	Antimicrobial/Antiseptic agent	Bacterial cell membrane and proteins
Lavasept 0.04%	Lavasept 0.04%	B. Braun Ltd. Centre of Excellence Infection Control	marketed	Antimicrobial antiseptic	Bacterial cell membrane and proteins
adapalene/benzoyl peroxide	adapalene/benzoyl peroxide	Galderma R&D	marketed	Retinoid + peroxide combination	Retinoic acid receptors (adapalene); bacterial cell membrane and proteins (benzoyl peroxide)
Chlorhexidine 0.2% Mouthrinse	Chlorhexidine 0.2% Mouthrinse	University of Oslo	marketed	Antimicrobial agent / Antiseptic	Bacterial cell membrane and proteins
Chlorhexidine rinse	Chlorhexidine rinse	Universidade Estadual Paulista Júlio de Mesquita Filho	marketed	Antimicrobial oral rinse	Bacterial cell membrane and proteins
Chlorhexidine oral care	Chlorhexidine oral care	University of Pavia	marketed	Antimicrobial agent / Antiseptic	Bacterial cell membrane and proteins
Adapalene/benzoyl peroxide gel, 0.1%/2.5%	Adapalene/benzoyl peroxide gel, 0.1%/2.5%	Galderma R&D	marketed	Retinoid + peroxide combination	Retinoic acid receptors (adapalene); bacterial cell membrane and proteins (benzoyl peroxide)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antimicrobial/Antiseptic agent class)

Altamash Institute of Dental Medicine · 1 drug in this class
Hamilton Health Sciences Corporation · 1 drug in this class
Riyadh Colleges of Dentistry and Pharmacy · 1 drug in this class
Sheikh Zayed Federal Postgraduate Medical Institute · 1 drug in this class
University of Oslo · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). .02% Chlorohexidine Gluconate — Competitive Intelligence Brief. https://druglandscape.com/ci/02-chlorohexidine-gluconate. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab